HistoSonics announced it has submitted a de novo request to the FDA seeking authorization to expand the use of its Edison ...
Stryker announced that it has completed the acquisition of Amplitude Vascular Systems, Inc. (AVS), which is developing a next-genera ...
Data from the PROMISE III trial suggest that chronic limb-threatening ischemia (CLTI) patients with no other treatment ...
Rapid Medical announced full results from the DISTALS randomized clinical trial demonstrating that the company’s Tigertriever ...
Cordis announced the launch in Japan of the Selution SLR percutaneous transluminal angioplasty (PTA) drug-eluting balloon ...
In the CARPOOL study, radial-to-peripheral (R2P) access achieved procedural success rates comparable to traditional common ...
Solaris Endovascular, Inc. announced that the FDA has granted Breakthrough Device designation for its Solaris DE drug-eluting ...
Teleflex Incorporated announced that Jason Weidman has been appointed President and Chief Executive Officer, effective June 8 ...
A comparative analysis from the ENGULF trial demonstrated that using blood return during continuous aspiration thrombectomy ...
April 29, 2026—enVVeno Medical Corporation announced it has received an FDA investigational device exemption (IDE) for the pivotal study of the ...
Hjarta Care announced that the FDA has granted de novo authorization for the EVAR XplantR, which is a purpose-built, ...
Cagent Vascular announced the publication of data demonstrating the safety and efficacy of the company’s Serranator percuta ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results